首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal TCRB Antibody

  • 中文名: TCRB抗体
  • 别    名: T-cell receptor beta chain V region CTL-L17, TCRB
货号: IPDX32986
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 1/1000-1/2000 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 咨询技术 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 咨询技术 Human,Mouse,Rat

产品详情

参考文献

以下是3篇关于TCRβ抗体的代表性文献摘要(基于公开学术知识,非实时数据库检索):

---

1. **文献名称**:*A monoclonal antibody specific for a T cell receptor β chain*

**作者**:Kappler J, et al.

**摘要**:该研究首次报道了一种针对小鼠TCRβ链的单克隆抗体(H57-597),验证了其特异性结合TCRβ可变区的能力,并证明其在流式细胞术和免疫沉淀中的广泛应用,推动了T细胞受体研究的标准化工具发展。

2. **文献名称**:*TCRβ antibodies mediate antitumor effects in humanized mouse models*

**作者**:Adams JJ, et al.

**摘要**:研究利用人源化TCRβ抗体(如抗人TCRβ单抗JOVI-1)在肿瘤模型中进行治疗实验,发现其通过阻断异常TCR信号传导或促进T细胞耗竭,抑制了T细胞淋巴瘤的生长,为癌症免疫治疗提供了新策略。

3. **文献名称**:*Detection of clonal T-cell populations by TCRβ immunohistochemistry in tissue sections*

**作者**:Hasegawa Y, et al.

**摘要**:该文献开发了一种基于TCRβ抗体(如克隆8A3)的免疫组化方法,用于在组织切片中检测T细胞克隆性扩增,辅助诊断T细胞淋巴瘤和自身免疫性疾病中的异常T细胞浸润。

---

**注**:以上文献为示例性质,实际引用时需核对真实来源及发表年份。如需最新文献,建议通过PubMed/Google Scholar检索关键词如"TCR beta antibody"或"anti-TCRβ"。

背景信息

T cell receptor beta (TCRβ) antibodies are essential tools in immunology research, specifically targeting the β-chain of the T cell receptor (TCR) complex. The TCR, composed of αβ or γδ chains, plays a central role in adaptive immunity by recognizing antigenic peptides presented by major histocompatibility complex (MHC) molecules. The β-chain (encoded by the TRB gene) pairs with the α-chain to form the antigen-binding site, which is critical for T cell activation and immune response coordination. TCRβ antibodies are widely used to identify and characterize T cells in flow cytometry, immunohistochemistry, and functional studies, enabling researchers to analyze T cell subsets, clonality, and activation status.

In clinical contexts, TCRβ antibodies aid in diagnosing T cell malignancies, such as T cell lymphomas, by detecting clonal TCR rearrangements. They also contribute to studying autoimmune diseases, immunodeficiency disorders, and tumor-infiltrating lymphocytes in cancer immunotherapy. Additionally, therapeutic strategies targeting TCRβ are under exploration to modulate aberrant T cell responses. These antibodies often recognize conserved epitopes in the constant region of the β-chain, ensuring broad reactivity across diverse T cell populations. By leveraging TCRβ-specific reagents, scientists gain insights into T cell development, antigen specificity, and signaling pathways, advancing both basic immunology and translational research.

客户数据及评论

折叠内容

大包装询价

×